Breaking News Instant updates and real-time market news.

PBYI

Puma Biotechnology

$11.31 /

-1.25 (-9.95%)

 08:13
02/26/20
 02/26
08:13
 02/26/20
08:13

Puma Biotechnology announces FDA approval of neratinib with capecitabine sNDA

Puma Biotechnology announced that the FDA approved a supplemental new drug application, or sNDA, for neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting. The sNDA approval was based on results of the Phase III NALA trial, a randomized controlled trial of neratinib plus capecitabine in patients with HER2-positive metastatic breast cancer who have received two or more prior anti-HER2-based regimens.
PBYI Puma Biotechnology
$11.31 /

-1.25 (-9.95%)

12/06/19 H.C. Wainwright
Puma Biotechnology initiated with a Buy at H.C. Wainwright
11/08/19 Cantor Fitzgerald
Puma Biotechnology price target lowered to $14 from $20 at Cantor Fitzgerald
11/07/19 RBC Capital
Puma Biotechnology price target lowered to $13 from $23 at RBC Capital
11/07/19 Barclays
Puma Biotechnology price target lowered to $6 from $9 at Barclays

TODAY'S FREE FLY STORIES

Hot Stocks
EOG Resources increases dividend 10% to 41.25c per share » 17:17
02/25/21
02/25
17:17
02/25/21
17:17
EOG

EOG Resources

$70.60 /

-1.79 (-2.47%)

EOG Resources increased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

01/04/21
EOG Resources names Ezra Yacob as President
11/05/20
EOG Resources provides three-year capital allocation outlook
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

02/02/21 Barclays
EOG Resources price target lowered to $60 from $67 at Barclays
01/22/21 Piper Sandler
EOG Resources price target raised to $70 from $60 at Piper Sandler
01/14/21 Barclays
EOG Resources downgraded to Equal Weight from Overweight at Barclays
01/11/21 Mizuho
EOG Resources price target raised to $88 from $71 at Mizuho
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

17:15 Today
EOG Resources reports Q4 adjusted EPS 71c, consensus 35c
11/05/20
EOG Resources reports Q3 adjusted EPS 43c, consensus 19c
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

02/17/21
Texas prohibits natgas firms from taking fuel out of state, Bloomberg says
10/27/20
President Trump weighing executive order to show support for fracking, WSJ says
10/16/20
Betaville says major oil company speculated to consider EOG bid, Bloomberg says
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

10/31/20
Week in review: How Trump's policies moved stocks
02/26/21
EOG Resources - EOG
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

01/27/21
EOG Resources put volume heavy and directionally bearish
12/14/20
EOG Resources put volume heavy and directionally bearish
12/07/20
EOG Resources put volume heavy and directionally bearish
10/26/20
EOG Resources call volume above normal and directionally bullish
Earnings
1Life Healthcare sees Q1 revenue $113M-$118M, consensus $108.93M » 17:17
02/25/21
02/25
17:17
02/25/21
17:17
ONEM

1Life Healthcare

$48.69 /

-3.24 (-6.24%)

Sees Q1 end membership…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

02/19/21
Tiger Global Management reports 5.7% passive stake in 1Life Healthcare
01/12/21
One Medical extends public COVID-19 vaccination effors
12/30/20
1Life Healthcare begins COVID-19 vaccination in San Francisco
09/30/20
One Medical, Houston Methodist to partner on coordinated care in Houston
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

02/04/21 Citi
1Life Healthcare price target raised to $62 from $42 at Citi
01/29/21 SVB Leerink
1Life Healthcare upgraded to Outperform from Market Perform at SVB Leerink
01/29/21 SVB Leerink
1Life Healthcare upgraded to Outperform from Market Perform at SVB Leerink
01/20/21 William Blair
1Life Healthcare jumps after William Blair sees vaccine rollout benefits
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

17:15 Today
1Life Healthcare reports Q4 EPS (6c), consensus (14c)
02/16/21
Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet
11/10/20
1Life Healthcare sees FY20 revenue $362M-$367M, consensus $333.88M
11/10/20
1Life Healthcare sees Q4 revenue $104M-$109M, consensus $90.9M
  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

05:48 Today
Three counties suspend Covid vaccine supply to 1Life, Chronicle reports
02/03/21
1Life Healthcare not enforcing Covid vaccine guidelines, Forbes reports
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

01/19/21
Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades
12/16/20
Teladoc slides on report of Amazon building telehealth business
11/10/20
Fly Intel: After-Hours Movers
16:30 Today
1Life Healthcare - ONEM
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

09/24/20
Unusually active option classes on open September 24th
Earnings
Noodles & Company reports Q4 EPS (4c), consensus 3c » 17:16
02/25/21
02/25
17:16
02/25/21
17:16
NDLS

Noodles & Company

$9.38 /

-0.135 (-1.42%)

Comparable restaurant…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDLS Noodles & Company
$9.38 /

-0.135 (-1.42%)

02/17/21
Noodles & Company announces multi-unit franchise growth initiative
11/02/20
Noodles & Company appoints Carl Lukach as CFO, Kathy Lockhart as CAO
10/01/20
Noodles & Company says over 90% of restaurants opened dining rooms
NDLS Noodles & Company
$9.38 /

-0.135 (-1.42%)

10/28/20
Noodles & Company reports Q3 adj. EPS 1c, consensus 0c
10/01/20
Noodles & Company sees Q3 revenue $106.3M, consenus $110.6M
  • 16
    Dec
  • 01
    Dec
  • 27
    Aug
NDLS Noodles & Company
$9.38 /

-0.135 (-1.42%)

10/28/20
Fly Intel: After-Hours Movers
16:30 Today
Noodles & Company - NDLS
Conference/Events
Eaton to host virtual investor day » 17:15
02/25/21
02/25
17:15
02/25/21
17:15
ETN

Eaton

$130.11 /

-2.64 (-1.99%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ETN Eaton
$130.11 /

-2.64 (-1.99%)

02/24/21
Eaton raises quarterly dividend 4% to 76c per share
02/01/21
Eaton to acquire Cobham Mission Systems for $2.83B
01/29/21
Eaton to acquire Tripp Lite for $1.65B
01/04/21
Eaton appoints Katrina Redmond as SVP, CIO
ETN Eaton
$130.11 /

-2.64 (-1.99%)

02/16/21
Eaton participates in a conference call with Wolfe Research
02/16/21
Fly Intel: Top five analyst upgrades
02/16/21 HSBC
Eaton upgraded to Buy from Hold at HSBC
02/16/21 HSBC
Eaton upgraded to Buy from Hold at HSBC
ETN Eaton
$130.11 /

-2.64 (-1.99%)

02/02/21
Eaton sees Q1 adjusted EPS $1.17-$1.27, consensus $1.05
02/02/21
Eaton sees FY21 adjusted EPS $5.40-$5.80, consensus $4.83
02/02/21
Eaton reports Q4 adjusted EPS $1.28, consensus $1.20
11/03/20
Eaton sees FY20 operating cash flow $2.8B-$3.0B
ETN Eaton
$130.11 /

-2.64 (-1.99%)

12/19/20
Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says
03/01/21
Eaton Corporation plc
Earnings
1Life Healthcare reports Q4 EPS (6c), consensus (14c) » 17:15
02/25/21
02/25
17:15
02/25/21
17:15
ONEM

1Life Healthcare

$48.69 /

-3.24 (-6.24%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

02/19/21
Tiger Global Management reports 5.7% passive stake in 1Life Healthcare
01/12/21
One Medical extends public COVID-19 vaccination effors
12/30/20
1Life Healthcare begins COVID-19 vaccination in San Francisco
09/30/20
One Medical, Houston Methodist to partner on coordinated care in Houston
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

02/04/21 Citi
1Life Healthcare price target raised to $62 from $42 at Citi
01/29/21 SVB Leerink
1Life Healthcare upgraded to Outperform from Market Perform at SVB Leerink
01/29/21 SVB Leerink
1Life Healthcare upgraded to Outperform from Market Perform at SVB Leerink
01/20/21 William Blair
1Life Healthcare jumps after William Blair sees vaccine rollout benefits
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

02/16/21
Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet
11/10/20
1Life Healthcare sees FY20 revenue $362M-$367M, consensus $333.88M
11/10/20
1Life Healthcare sees Q4 revenue $104M-$109M, consensus $90.9M
11/10/20
1Life Healthcare reports Q3 EPS (13c), consensus (19c)
  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

05:48 Today
Three counties suspend Covid vaccine supply to 1Life, Chronicle reports
02/03/21
1Life Healthcare not enforcing Covid vaccine guidelines, Forbes reports
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

01/19/21
Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades
12/16/20
Teladoc slides on report of Amazon building telehealth business
11/10/20
Fly Intel: After-Hours Movers
16:30 Today
1Life Healthcare - ONEM
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

09/24/20
Unusually active option classes on open September 24th
Earnings
EOG Resources reports Q4 adjusted EPS 71c, consensus 35c » 17:15
02/25/21
02/25
17:15
02/25/21
17:15
EOG

EOG Resources

$70.60 /

-1.79 (-2.47%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

01/04/21
EOG Resources names Ezra Yacob as President
11/05/20
EOG Resources provides three-year capital allocation outlook
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

02/02/21 Barclays
EOG Resources price target lowered to $60 from $67 at Barclays
01/22/21 Piper Sandler
EOG Resources price target raised to $70 from $60 at Piper Sandler
01/14/21 Barclays
EOG Resources downgraded to Equal Weight from Overweight at Barclays
01/11/21 Mizuho
EOG Resources price target raised to $88 from $71 at Mizuho
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

11/05/20
EOG Resources reports Q3 adjusted EPS 43c, consensus 19c
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

02/17/21
Texas prohibits natgas firms from taking fuel out of state, Bloomberg says
10/27/20
President Trump weighing executive order to show support for fracking, WSJ says
10/16/20
Betaville says major oil company speculated to consider EOG bid, Bloomberg says
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

10/31/20
Week in review: How Trump's policies moved stocks
02/26/21
EOG Resources - EOG
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

01/27/21
EOG Resources put volume heavy and directionally bearish
12/14/20
EOG Resources put volume heavy and directionally bearish
12/07/20
EOG Resources put volume heavy and directionally bearish
10/26/20
EOG Resources call volume above normal and directionally bullish
Syndicate
Edesa Biotech announces $3.5M bought deal offering of common shares » 17:14
02/25/21
02/25
17:14
02/25/21
17:14
EDSA

Edesa Biotech

$6.60 /

+0.2 (+3.13%)

Edesa Biotech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EDSA Edesa Biotech
$6.60 /

+0.2 (+3.13%)

01/26/21
Edesa Biotech receives FDA, Health Canada approval for EB05 sub-study
01/11/21
Edesa Biotech expands COVID-19 clinical study to Colombia
11/03/20
Edesa Biotech completes enrollment of over 50% of patients for EB01 cream cohort
10/19/20
Edesa Biotech receives FDA clearance to begin EB05 study in COVID-19 patients
EDSA Edesa Biotech
$6.60 /

+0.2 (+3.13%)

03/30/20 Brookline
Edesa Biotech initiated with a Buy at Brookline
Earnings
Vicor reports Q4 EPS 25c, consensus 17c » 17:13
02/25/21
02/25
17:13
02/25/21
17:13
VICR

Vicor

$90.00 /

-5.23 (-5.49%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VICR Vicor
$90.00 /

-5.23 (-5.49%)

09/15/20
Vicor announces global distribution agreement with Arrow Electronics
VICR Vicor
$90.00 /

-5.23 (-5.49%)

12/30/20 Needham
Needham names Applied Materials top pick in 2021, boosts price target to $110
10/23/20 Needham
Vicor price target raised to $95 from $85 at Needham
09/18/20 Northland
Combined Nvidia-ARM a long-term risk for AMD, Intel and Vicor, says Northland
07/24/20 BWS Financial
Vicor price target raised to $100 from $84 at BWS Financial
VICR Vicor
$90.00 /

-5.23 (-5.49%)

10/22/20
Vicor reports Q3 EPS 13c, consensus 8c
  • 11
    Jun
17:00 Today
Vicor - VICR
Earnings
Mirati Therapeutics reports Q4 EPS ($2.08), consensus (2.23) » 17:13
02/25/21
02/25
17:13
02/25/21
17:13
MRTX

Mirati Therapeutics

$195.44 /

-6.96 (-3.44%)

Reports Q4 revenue $1.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$195.44 /

-6.96 (-3.44%)

02/10/21
Mirati Therapeutics, MD Anderson announce KRAS research agreement
10/25/20
Mirati reports preliminary results from mutant KRAS selective inhibitor programs
09/18/20
Mirati Therapeutics presents Phase 2 sitravatinib/nivolumab data at ESMO
09/17/20
Mirati Therapeutics, Boehringer collaborate on BI 1701963/MRTX849 combination
MRTX Mirati Therapeutics
$195.44 /

-6.96 (-3.44%)

01/15/21 H.C. Wainwright
Mirati Therapeutics price target lowered to $257 from $265 at H.C. Wainwright
12/08/20 JMP Securities
Mirati Therapeutics initiated with a Market Perform at JMP Securities
11/17/20 BofA
Mirati Therapeutics downgraded to Underperform from Neutral at BofA
11/10/20 Guggenheim
Mirati Therapeutics downgraded to Neutral from Buy at Guggenheim
MRTX Mirati Therapeutics
$195.44 /

-6.96 (-3.44%)

11/04/20
Mirati Therapeutics reports Q3 EPS ($1.96), consensus ($1.97)
  • 28
    Oct
MRTX Mirati Therapeutics
$195.44 /

-6.96 (-3.44%)

10/26/20
Fly Intel: After-Hours Movers
10/26/20
Fly Intel: Wall Street's top stories for Monday
10/26/20
Fly Intel: Wall Street's top stories at midday
03/01/21
41st Annual Healthcare Virtual Conference
Syndicate
AvalonBay files automatic mixed securities shelf  17:12
02/25/21
02/25
17:12
02/25/21
17:12
AVB

AvalonBay

$180.39 /

-4.67 (-2.52%)

 
ShowHide Related Items >><<
AVB AvalonBay
$180.39 /

-4.67 (-2.52%)

12/10/20
AvalonBay names Benjamin Schall president
AVB AvalonBay
$180.39 /

-4.67 (-2.52%)

02/22/21 KeyBanc
AvalonBay upgraded to Overweight at KeyBanc on coastal recovery
02/21/21 KeyBanc
AvalonBay upgraded to Overweight from Sector Weight at KeyBanc
02/09/21 BofA
Camden Property downgraded to Neutral from Buy at BofA
12/21/20 JPMorgan
JPMorgan changes ratings in REIT, Real Estate Services sectors into 2021
AVB AvalonBay
$180.39 /

-4.67 (-2.52%)

02/03/21
AvalonBay Communities sees Q1 core FFO $1.85-$1.95
02/03/21
AvalonBay Communities reports Q4 core FFO $2.43, consensus $2.09
10/28/20
AvalonBay reports Q3 EPS $1.05, consensus 95c
Conference/Events
Viatris to host virtual investor day » 17:11
02/25/21
02/25
17:11
02/25/21
17:11
VTRS

Viatris

$15.05 /

-0.245 (-1.60%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VTRS Viatris
$15.05 /

-0.245 (-1.60%)

02/22/21
Viatris to initiate 11c per share quarterly dividend in May
01/28/21
FTC approves final order on Pfizer, Mylan deal with conditions
12/21/20
Mapi Pharma provides enrollment update on Phase III GA Depot trial
12/18/20
Viatris acquires 27,736 common shares
VTRS Viatris
$15.05 /

-0.245 (-1.60%)

02/23/21 Barclays
Viatris price target lowered to $20 from $26 at Barclays
01/06/21 RBC Capital
Viatris named one of top stocks to own in 2021 by RBC Capital
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/14/20 Bernstein
Viatris initiated with a Market Perform at Bernstein
VTRS Viatris
$15.05 /

-0.245 (-1.60%)

02/22/21
Viatris sees FY21 revenue $17.2B-$17.8B, consensus $18.46B
03/01/21
Viatris Inc
VTRS Viatris
$15.05 /

-0.245 (-1.60%)

02/19/21
Viatris call volume above normal and directionally bullish
02/08/21
Viatris put volume heavy and directionally bearish
01/14/21
Viatris call volume above normal and directionally bullish
12/31/20
Viatris call volume above normal and directionally bullish
Hot Stocks
Beyond Meat says 'not prepared to elaborate' on new partnerships » 17:11
02/25/21
02/25
17:11
02/25/21
17:11
BYND

Beyond Meat

$143.89 /

-8.21 (-5.40%)

Says plans to hold…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

16:16 Today
Beyond Meat partners with Yum! Brands on plant-based protein menu items
16:14 Today
Beyond Meat signs three-year agreement to be McPlant supplier for McDonald's
16:13 Today
Beyond Meat not providing FY21 guidance until further notice
02/09/21
Beyond Meat director sells 40K shares of common stock
BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

02/03/21
Fly Intel: Top five analyst downgrades
02/03/21 DA Davidson
Beyond Meat downgraded to Underperform from Neutral at DA Davidson
02/03/21 DA Davidson
Beyond Meat downgraded to Underperform from Neutral at DA Davidson
01/27/21 Canaccord
Beyond Meat price target raised to $170 from $125 at Canaccord
BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

16:12 Today
Beyond Meat reports Q4 adjusted EPS (34c), consensus (13c)
13:52 Today
Notable companies reporting after market close
11/09/20
Beyond Meat reports Q3 adj. EPS (28c), consensus 5c
11/09/20
Notable companies reporting after market close
BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

02/04/21
Lawsuit challenging FDA approval of Impossible color additive, FSN reports
02/01/21
McDonald's begins introduction of McPlant Burger in test markets, Bloomberg says
11/09/20
Beyond Meat up 4% after confirming partnership with McDonald's for 'McPlant'
11/09/20
Beyond Meat says co-created 'McPlant' burger with McDonald's, Reuters reports
BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

11:47 Today
Fly Intel: What to watch in Beyond Meat earnings report
02/03/21
Beyond Meat downgrade, Comcast upgrade among today's top calls on Wall Street
01/27/21
Fly Intel: What to watch in McDonald's earnings report
01/26/21
Fly Intel: Wall Street's top stories for Tuesday
17:00 Today
Beyond Meat - BYND
BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

01/25/21
Beyond Meat call volume above normal and directionally bullish
01/22/21
Beyond Meat call volume above normal and directionally bullish
01/13/21
Largest borrow rate increases among liquid names
11/18/20
Unusually active option classes on open November 18th
Earnings
AnaptysBio reports Q4 EPS $1.20, consensus $1.39 » 17:11
02/25/21
02/25
17:11
02/25/21
17:11
ANAB

AnaptysBio

$26.00 /

-0.39 (-1.48%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$26.00 /

-0.39 (-1.48%)

11/04/20
AnaptysBio sees net cash burn in FY20 'will be close to breakeven'
11/04/20
AnaptysBio sees net cash burn in FY20 'will be close to breakeven'
10/26/20
AnaptysBio, GlaxoSmithKline amend strategic immuno-oncology collaboration
10/13/20
AnaptysBio reports topline data from GALLOP Phase 2 trial of imsidolimab
ANAB AnaptysBio
$26.00 /

-0.39 (-1.48%)

02/11/21 JPMorgan
JPMorgan double upgrades AnaptysBio, more than doubles price target
02/11/21 JPMorgan
AnaptysBio upgraded to Overweight from Underweight at JPMorgan
10/27/20
Fly Intel: Top five analyst upgrades
10/27/20 Truist
AnaptysBio price target raised to $27 from $20 at Truist
ANAB AnaptysBio
$26.00 /

-0.39 (-1.48%)

11/04/20
AnaptysBio reports Q3 EPS (87c), consensus (72c)
ANAB AnaptysBio
$26.00 /

-0.39 (-1.48%)

02/11/21
Zillow, Bed Bath & Beyond upgrades among today's top calls on Wall Street
Earnings
Erie Indemnity reports Q4 EPS $1.20 , consensus $1.21 » 17:11
02/25/21
02/25
17:11
02/25/21
17:11
ERIE

Erie Indemnity

$243.85 /

-4.15 (-1.67%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ERIE Erie Indemnity
$243.85 /

-4.15 (-1.67%)

12/08/20
Erie Indemnity approves management fee rate, raises dividend
09/01/20
Erie appoints Jamie Neumaier as Chief Information Security Officer
ERIE Erie Indemnity
$243.85 /

-4.15 (-1.67%)

10/29/20
Erie Indemnity reports Q3 EPS $1.71, consensus $1.50
02/26/21
Erie Indemnity - ERIE
Earnings
Nektar reports Q4 EPS (65c), consensus (68c) » 17:09
02/25/21
02/25
17:09
02/25/21
17:09
NKTR

Nektar

$22.47 /

-0.29 (-1.27%)

Reports Q4 revenue $23.5…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKTR Nektar
$22.47 /

-0.29 (-1.27%)

02/17/21
Nektar announces collaboration with SFJ Pharmaceuticals
02/17/21
Nektar enters trial collaboration, supply agreement with Merck
01/05/21
Nektar names Brian Kotzin interim chief medical officer
12/22/20
Nektar sells royalties on future sales of ADYNOVATE and MOVANTIK
NKTR Nektar
$22.47 /

-0.29 (-1.27%)

02/22/21 Benchmark
Nektar downgraded to Hold on valuation at Benchmark
02/22/21 Benchmark
Nektar downgraded to Hold from Buy at Benchmark
02/17/21 William Blair
William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ
02/17/21 Piper Sandler
Nektar collaborations could create $500M-$800M opportunity, says Piper Sandler
NKTR Nektar
$22.47 /

-0.29 (-1.27%)

11/05/20
Nektar reports Q3 EPS (61c), consensus (74c)
03/01/21
41st Annual Healthcare Virtual Conference
17:00 Today
Nektar - NKTR
Earnings
Codexis sees FY21 revenue $82M-$85M, consensus $80.53M » 17:08
02/25/21
02/25
17:08
02/25/21
17:08
CDXS

Codexis

$21.23 /

-1.67 (-7.29%)

Sees FY21 adjusted gross…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

01/13/21
Codexis, Tate & Lyle expand relationship to enhance stevia, allulose production
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

12/30/20 Benchmark
Codexis price target raised to $29 from $21 at Benchmark
07/15/20 Stephens
Codexis resumed with an Overweight at Stephens
03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

17:06 Today
Codexis reports Q4 EPS (6c), consensus (12c)
11/05/20
Codexis reports Q3 EPS (10c), consensus (11c)
  • 03
    Dec
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

12/03/20
Fly Intel: Wall Street's top stories for Thursday
12/03/20
Fly Intel: Wall Street's top stories at midday
12/03/20
Fly Intel: Pre-market Movers
03/01/21
41st Annual Healthcare Virtual Conference
03/15/21
33rd Annual Roth Virtual Conference
16:30 Today
Codexis - CDXS
Earnings
Assembly Biosciences reports Q4 EPS ($1.75), consensus (90c) » 17:08
02/25/21
02/25
17:08
02/25/21
17:08
ASMB

Assembly Biosciences

$5.53 /

-0.13 (-2.30%)

"Our strategy for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASMB Assembly Biosciences
$5.53 /

-0.13 (-2.30%)

12/08/20
Assembly Biosciences to wind-down microbiome program
11/17/20
Assembly Biosciences appoints SVP, pharmaceutical development and manufacturing
11/16/20
Assembly Biosciences, Door Pharmaceuticals sign collaboration agreement
11/13/20
Assembly Biosciences presents data from HBV core inhibitor programs
ASMB Assembly Biosciences
$5.53 /

-0.13 (-2.30%)

12/04/20 Mizuho
Assembly Biosciences price target lowered to $13 from $30 at Mizuho
11/06/20 Jefferies
Assembly Biosciences downgraded to Hold from Buy at Jefferies
10/19/20 Truist
Assembly Biosciences initiated with a Buy at Truist
07/21/20 Baird
Assembly Biosciences HBV deal a positive, says Baird
ASMB Assembly Biosciences
$5.53 /

-0.13 (-2.30%)

11/05/20
Assembly Biosciences reports Q3 EPS (9c), consensus (75c)
ASMB Assembly Biosciences
$5.53 /

-0.13 (-2.30%)

11/05/20
Fly Intel: After-Hours Movers
Earnings
Pembina Pipeline reports Q4 EPS ($2.28), may not compare to consensus 44c » 17:08
02/25/21
02/25
17:08
02/25/21
17:08
PBA

Pembina Pipeline

$27.50 /

-0.645 (-2.29%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PBA Pembina Pipeline
$27.50 /

-0.645 (-2.29%)

01/19/21
Pembina Pipeline announces binding open season
12/14/20
Pembina Pipeline sees FY21 CapEx $730M
12/14/20
Pembina Pipeline sees 2021 adjusted EBITDA $3.2B-$3.4B
PBA Pembina Pipeline
$27.50 /

-0.645 (-2.29%)

02/09/21 Scotiabank
Pembina Pipeline downgraded to Sector Perform from Outperform at Scotiabank
01/27/21 Credit Suisse
Pembina Pipeline price target raised to C$42 from C$40 at Credit Suisse
01/27/21 National Bank
Pembina Pipeline price target raised to C$38 from C$36 at National Bank
01/22/21 Stifel
Pembina Pipeline price target raised to C$37 from C$34 at Stifel
02/26/21
Pembina Pipeline - PBA
Earnings
Ranger Energy reports Q4 EPS (43c), consensus (31c) » 17:06
02/25/21
02/25
17:06
02/25/21
17:06
RNGR

Ranger Energy

$5.54 /

+0.09 (+1.65%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RNGR Ranger Energy
$5.54 /

+0.09 (+1.65%)

01/04/21 Evercore ISI
Ranger Energy upgraded to Outperform from In Line at Evercore ISI
12/10/20 B. Riley Securities
Ranger Energy upgraded to Buy on valuation at B. Riley Securities
12/10/20 B. Riley Securities
Ranger Energy upgraded to Buy from Neutral at B. Riley Securities
04/15/20 Piper Sandler
Ranger Energy downgraded to Neutral from Overweight at Piper Sandler
RNGR Ranger Energy
$5.54 /

+0.09 (+1.65%)

10/22/20
Ranger Energy reports Q3 EPS (38c), consensus (45c)
03/01/21
26th Annual Energy Virtual Summit
02/26/21
Ranger Energy - RNGR
Earnings
Fly Leasing reports Q4 adjusted EPS ($3.78), consensus (15c) » 17:06
02/25/21
02/25
17:06
02/25/21
17:06
FLY

Fly Leasing

$12.42 /

-0.19 (-1.51%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLY Fly Leasing
$12.42 /

-0.19 (-1.51%)

12/23/20
Fly Leasing rises 22.8%
09/28/20
Fly Leasing rises 19.2%
FLY Fly Leasing
$12.42 /

-0.19 (-1.51%)

01/26/21 Cowen
Fly Leasing price target raised to $13 from $9 at Cowen
01/25/21 Deutsche Bank
Fly Leasing price target raised to $11 from $8.50 at Deutsche Bank
11/16/20 Deutsche Bank
Fly Leasing price target lowered to $8.50 from $10 at Deutsche Bank
05/26/20 JPMorgan
JPMorgan upgrades Fly Leasing with stock rally lagging peers
FLY Fly Leasing
$12.42 /

-0.19 (-1.51%)

11/12/20
Fly Leasing reports Q3 adjusted EPS (30c), consensus 36c
FLY Fly Leasing
$12.42 /

-0.19 (-1.51%)

12/23/20
Fly Leasing rallies after Airfinance Journal says considering sale
16:30 Today
Fly Leasing - FLY
Earnings
Codexis reports Q4 EPS (6c), consensus (12c) » 17:06
02/25/21
02/25
17:06
02/25/21
17:06
CDXS

Codexis

$21.23 /

-1.67 (-7.29%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

01/13/21
Codexis, Tate & Lyle expand relationship to enhance stevia, allulose production
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

12/30/20 Benchmark
Codexis price target raised to $29 from $21 at Benchmark
07/15/20 Stephens
Codexis resumed with an Overweight at Stephens
03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

11/05/20
Codexis reports Q3 EPS (10c), consensus (11c)
  • 03
    Dec
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

12/03/20
Fly Intel: Wall Street's top stories for Thursday
12/03/20
Fly Intel: Wall Street's top stories at midday
12/03/20
Fly Intel: Pre-market Movers
03/01/21
41st Annual Healthcare Virtual Conference
03/15/21
33rd Annual Roth Virtual Conference
16:30 Today
Codexis - CDXS
Hot Stocks
Southwest Gas sees FY21 CapEx approximately $700M  17:05
02/25/21
02/25
17:05
02/25/21
17:05
SWX

Southwest Gas

$64.17 /

-0.955 (-1.47%)

 
ShowHide Related Items >><<
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

02/24/21
Southwest Gas increases quarterly dividend 4.4% to 59.5c per share
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

01/29/21
Fly Intel: Top five analyst downgrades
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral on regulatory risk at JPMorgan
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral from Overweight at JPMorgan
12/10/20 BofA
Southwest Gas cut to Underperform at BofA after AZ rate case decision
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

17:05 Today
Southwest Gas sees FY21 EPS $3.95-$4.20, consensus $4.18
17:04 Today
Southwest Gas reports Q4 EPS $1.82, consensus $1.61
11/05/20
Southwest Gas backs FY20 EPS view $3.75-$4.00, consensus $3.88
11/05/20
Southwest Gas reports Q3 EPS 32c, consensus 24c
02/26/21
Southwest Gas - SWX
Earnings
Southwest Gas sees FY21 EPS $3.95-$4.20, consensus $4.18  17:05
02/25/21
02/25
17:05
02/25/21
17:05
SWX

Southwest Gas

$64.17 /

-0.955 (-1.47%)

 
ShowHide Related Items >><<
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

02/24/21
Southwest Gas increases quarterly dividend 4.4% to 59.5c per share
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

01/29/21
Fly Intel: Top five analyst downgrades
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral on regulatory risk at JPMorgan
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral from Overweight at JPMorgan
12/10/20 BofA
Southwest Gas cut to Underperform at BofA after AZ rate case decision
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

17:04 Today
Southwest Gas reports Q4 EPS $1.82, consensus $1.61
11/05/20
Southwest Gas backs FY20 EPS view $3.75-$4.00, consensus $3.88
11/05/20
Southwest Gas reports Q3 EPS 32c, consensus 24c
02/26/21
Southwest Gas - SWX
Earnings
Southwest Gas reports Q4 EPS $1.82, consensus $1.61 » 17:04
02/25/21
02/25
17:04
02/25/21
17:04
SWX

Southwest Gas

$64.17 /

-0.955 (-1.47%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

02/24/21
Southwest Gas increases quarterly dividend 4.4% to 59.5c per share
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

01/29/21
Fly Intel: Top five analyst downgrades
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral on regulatory risk at JPMorgan
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral from Overweight at JPMorgan
12/10/20 BofA
Southwest Gas cut to Underperform at BofA after AZ rate case decision
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

11/05/20
Southwest Gas backs FY20 EPS view $3.75-$4.00, consensus $3.88
11/05/20
Southwest Gas reports Q3 EPS 32c, consensus 24c
02/26/21
Southwest Gas - SWX
Earnings
PetIQ reports Q4 EPS (41c), consensus (10c) » 17:04
02/25/21
02/25
17:04
02/25/21
17:04
PETQ

PetIQ

$37.25 /

+1.77 (+4.99%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PETQ PetIQ
$37.25 /

+1.77 (+4.99%)

11/05/20
PetIQ re-opened ~95% of community clinics, wellness centers as of September 30
09/08/20
PetIQ provides reopening update
PETQ PetIQ
$37.25 /

+1.77 (+4.99%)

10/15/20 Jefferies
PetIQ assumed with a Buy at Jefferies
08/17/20 Guggenheim
Zoetis price target raised to $175 from $139 at Guggenheim
07/01/20 Raymond James
PetIQ price target raised to $41 from $35 at Raymond James
06/25/20 Guggenheim
PetIQ price target raised to $44 from $33.50 at Guggenheim
PETQ PetIQ
$37.25 /

+1.77 (+4.99%)

11/05/20
PetIQ says FY20 guidance remains suspended due to COVID-19
11/05/20
PetIQ reports Q3 EPS ($2.53), may not compare to consensus 16c
16:30 Today
PetIQ - PETQ
03/09/21
PetIQ
PETQ PetIQ
$37.25 /

+1.77 (+4.99%)

11/30/20
Largest borrow rate increases among liquid names

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.